Ketorolac or ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives used as an analgesic. Ketorolac was discovered in 1989 by Syntex Corp. (now Roche Bioscience which is a wholly owned subsidiary of Roche holding Ltd. the parent company of Roche). It was approved by FDA on 30 November 1989 and introduced as Toradol by Syntex.
This page contains content from the copyrighted Wikipedia article "Ketorolac"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
